Saturday March 23, 2019

Optimism May Lower Diabetes Risk in Postmenopausal Women: Study

The prevalence of diabetes increases with age, with a 25.2 per cent prevalence in those aged 65 years or older

0
//
Pregnancy
The study included 4,697 mothers and 4,832 children. (IANS)

While it is known that a positive personality can help one succeed in life, a new study suggests that traits such as optimism may actually help reduce the risk of developing Type-2 diabetes.

The study examined whether personality traits, including optimism, negativity, and hostility, were associated with the risk of developing Type-2 diabetes in postmenopausal women.

Depression and cynicism were found to be associated with an increased risk of diabetes.

In addition, high levels of hostility were associated with high fasting glucose levels, insulin resistance, and prevalent diabetes.

For the study, published in the journal Menopause, researchers followed 139,924 postmenopausal women amongst which 19,240 cases of Type-2 diabetes were identified.

Diabetes
Representational image. Pixabay

Compared with women who were least optimistic, women who were the most optimistic had a 12 per cent lower risk of incident diabetes, results showed.

In addition, the association of hostility with the risk of diabetes was stronger in women who were not obese compared with women who were.

Hence, low optimism, high negativity and hostility were associated with increased risk of incident diabetes in postmenopausal women, independent of major health behaviours and depressive symptoms, the study concluded.

Also Read- It is Now Possible to Reverse Memory Loss Caused by Alzheimer’s, Says Study

“In addition to using personality traits to help us identify women at higher risk for developing diabetes, more individualised education and treatment strategies should also be used,” said Joann Pinkerton, executive director at The North American Menopause Society.

The prevalence of diabetes increases with age, with a 25.2 per cent prevalence in those aged 65 years or older. (IANS)

Next Story

Cardiovascular Events Cause 58% Deaths Among Diabetics

The medicine likewise helps lower the amount of sodium in the body and reduce triglyceride levels and blood pressure

0
Diabetes
Representational image. Pixabay

Fifty-eight percent of deaths among people with type 2 diabetes are due to cardiovascular events, a leading Mexican expert has said.

“Patients who live with this disease have a greater risk of premature death or disability derived from cardiovascular events,” Hector Sanchez Mijangos, President of the Mexican Diabetes Federation, told Efe news.

The specialist said that the high glucose levels associated with diabetes damage blood vessels, resulting in problems with blood pressure and vision, joint pain and other maladies.

Data from the World Health Organization indicate that more 442 million people suffer from type 2 diabetes.

Mexico’s Health Secretariat has found that while roughly 13 million inhabitants of the Aztec nation are living with diabetes, only half of those afflicted know they have the disease.

In 2015 alone, according to Mijangos, there were more than 98,000 premature deaths in Mexico related to diabetes and the average age of those who died was 66.7 years old.

Diabetes
Representational image. Pixabay

“This is regrettable, because these people could have lived roughly another 15 years,” he said.

According to the 2012 National Health and Nutrition Survey, only 25 percent of Mexicans suffering with diabetes are managing their condition adequately.

That figure illustrates “why our greatest challenge continues to be access and adherence to treatment”, Mijangos said.

Also Read- Researchers Discover Balance of Two Enzymes That May Help Treat Pancreatic Cancer

To improve treatment options, Mexican health authorities in January issued an approval for the use of canagliflozin, a drug that helps reduce the amount of blood glucose reabsorbed by the kidneys, which in turns causes more glucose to be eliminated through urination.

“With this medicine, a person can lose 100 milligrams of glucose per day as well as about 400 kilocalories (4,000 calories) a day, which also helps with weight loss,” Mijangos said.

The medicine likewise helps lower the amount of sodium in the body and reduce triglyceride levels and blood pressure.

A scientific trial involving more than 10,000 patients worldwide showed that when combined with conventional treatment, canagliflozin can reduce the incidence of cardiovascular events by up to 18 percent. (IANS)